NanoFlares for the detection, isolation, and culture of live tumor cells from human blood

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 48, 2014, Pages 17104-17109

  Halo, Tiffany L ^a,b   McMahon, Kaylin M ^c,d   Angeloni, Nicholas L ^c,d   Xu, Yilin ^c   Wang, Wei ^c   Chinen, Alyssa B ^a,b   Malin, Dmitry ^e   Strekalova, Elena ^e   Cryns, Vincent L ^e   Cheng, Chonghui ^c   Mirkin, Chad A ^a,b   Thaxton, C Shad ^b,c,d  

^a Department of Chemistry ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cancer metastasis |; Diagnostic |; MRNA |; NanoFlares; Nanotechnology |

Indexed keywords

MURINAE;

CADHERIN; CARBOCYANINE; COMPLEMENTARY DNA; CYANINE DYE 5; FIBRONECTIN; GOLD; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; METAL NANOPARTICLE; PHOTOPROTEIN; RED FLUORESCENT PROTEIN; TUMOR MARKER; VIMENTIN;

BLOOD; BREAST TUMOR; CHEMISTRY; FEMALE; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; METABOLISM; NANOTECHNOLOGY; NUCLEOTIDE SEQUENCE; PROCEDURES; TUMOR CELL LINE; TUMOR EMBOLISM; XENOGRAFT;

BASE SEQUENCE; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CADHERINS; CARBOCYANINES; CELL LINE, TUMOR; DNA, ANTISENSE; FEMALE; FIBRONECTINS; GOLD; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; METAL NANOPARTICLES; MICROSCOPY, FLUORESCENCE; NANOTECHNOLOGY; NEOPLASTIC CELLS, CIRCULATING; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; VIMENTIN;

EID: 84914127560     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1418637111     Document Type: Article

References (28)

1. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411(6835):375-379.
2. Chiang AC, Massagué J (2008) Molecular basis of metastasis. N Engl J Med 359(26): 2814-2823.
3. Cristofanilli M, et al. (2005) Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23(7):1420-1430.
4. Budd GT, et al. (2006) Circulating tumor cells versus imaging: Predicting overall survival in metastatic breast cancer. Clin Cancer Res 12(21):6403-6409.
5. Hayes DF, et al. (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12(14 Pt 1):4218-4224.
6. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8(5):329-340.
7. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420-1428.
8. Sarrió D, et al. (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68(4):989-997.
9. Zajchowski DA, et al. (2001) Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61(13):5168-5178.
10. May CD, et al. (2011) Epithelial-mesenchymal transition and cancer stem cells: A dangerously dynamic duo in breast cancer progression. Breast Cancer Res 13(1):202.
11. Gunasinghe NPAD, Wells A, Thompson EW, Hugo HJ (2012) Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev 31(3-4):469-478.
12. Allard WJ, et al. (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20):6897-6904.
13. LiuMC, et al. (2009) Circulating tumor cells: A useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol 27(31):5153-5159.
14. Riethdorf S, et al. (2007) Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system. Clin Cancer Res 13(3):920-928.
15. Gupta GP, et al. (2005) Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 70:149-158.
16. Yu M, Stott S, Toner M, Maheswaran S, Haber DA (2011) Circulating tumor cells: Approaches to isolation and characterization. J Cell Biol 192(3):373-382.
17. Choi CHJ, Hao L, Narayan SP, Auyeung E, Mirkin CA (2013) Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates. Proc Natl Acad Sci USA 110(19):7625-7630.
18. Prigodich AE, et al. (2012) Multiplexed nanoflares: mRNA detection in live cells. Anal Chem 84(4):2062-2066.
19. Seferos DS, Giljohann DA, Hill HD, Prigodich AE, Mirkin CA (2007) Nano-flares: Probes for transfection and mRNA detection in living cells. J AmChem Soc 129(50):15477-15479.
20. Giljohann DA, et al. (2010) Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl 49(19):3280-3294.
21. Prigodich AE, Alhasan AH, Mirkin CA (2011) Selective enhancement of nucleases by polyvalent DNA-functionalized gold nanoparticles. J Am Chem Soc 133(7):2120-2123.
22. Massich MD, Giljohann DA, Schmucker AL, Patel PC, Mirkin CA (2010) Cellular response of polyvalent oligonucleotide-gold nanoparticle conjugates. ACS Nano 4(10):5641-5646.
23. Yang J, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7):927-939.
24. Brown RL, et al. (2011) CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 121(3):1064-1074.
25. Noble PBC, Cutts JH (1967) Separation of blood leukocytes by Ficoll gradient. Can Vet J 8(5):110-111.
26. Malin D, et al. (2014) αB-crystallin: A novel regulator of breast cancer metastasis to the brain. Clin Cancer Res 20(1):56-67.
27. Malin D, Chen F, Schiller C, Koblinski J, Cryns VL (2011) Enhanced metastasis suppression by targeting TRAIL receptor 2 in a murine model of triple-negative breast cancer. Clin Cancer Res 17(15):5005-5015.
28. Moody SE, et al. (2005) The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8(3):197-209.